Summer 2022 Newsletter

Published on 08/31/2022

12 min read

Attend/Stream the Event

Our first-ever Investor Day is on September 20th in NYC! We’ll be streaming live as our execs discuss the latest news and innovations in our journey to democratize Data-Driven Medicine.

New HRD Publication

Check out our latest publication. You’ll learn more about the SOPHiA GENETICS Genomic Integrity Index (GII), a deep-learning algorithm detecting clinically relevant genomic scarring.

RNAtarget Oncology Solutions

Cancer management outcomes can strongly benefit from robust and accurate detection of gene fusions. SOPHiA GENETICS developed the SOPHiA DDM Dx RNAtarget Oncology Solution to make this possible. We list 7 reasons to consider SOPHiA DDM Dx RNAtarget Oncology Solution for your assays.

Trio Analysis Case Study

Check out our latest case study discussing the use of the SOPHiA DDM™️ Platform to identify a variant related to neonatal death using trio analysis of the family.

Tech Talk: Achieve sensitive and precise CNV calling with SOPHiA DDM™

Bita Khalili is a Senior Algorithm Researcher in our SOPHiA GENETICS Data Science team. She joined the team after completing her PhD in Physics and a post-doctoral research position in Bioinformatics. For the last two years, Bita has been analyzing NGS data at SOPHiA GENETICS and developing copy number variation (CNV) detection modules.

pink dots icon

Upcoming Events

[facetwp template=”events_grid”]

pink dots icon

In The News

The Healthcare Technology Report

The Top 100 Healthcare Technology Companies of 2022

Microsoft

Swiss Partner of the Year Awards

Built In Boston

Help Shape Industry Defining Products At These Boston Healthtech Companies

Pharma's Almanac

Q: What important company milestone do you anticipate reaching in 2022?

Pharma's Almanac

Q: What’s the key to being a leader in the industry?

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.
';